Home › Calculator › GNNSF Dividend Calculator 2026
GNNSF Dividend Calculator 2026
No dividendHealthcareGenscript Biotech Corporation · OTC
Price: $4.25 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
GNNSF is not a dividend-focused stock
GNNSF pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
GNNSF Dividend Yield
Genscript Biotech Corporation (GNNSF) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When GNNSF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Genscript Biotech Corporation (GNNSF) — Dividend Analysis 2026
Genscript Biotech Corporation, an investment holding firm, operates on a global scale as a leading provider of life science research products and services, serving North America, Europe, China, Japan, other Asia Pacific regions, and beyond. The company is structured into four distinct business units. Its Life Science Services and Products division delivers essential research support, encompassing gene synthesis, molecular cloning, oligonucleotide and peptide synthesis, protein engineering, antibody development, and the creation of molecular diagnostic tools and genome editing materials. These offerings cater to diverse fields such as fundamental biological research, pharmaceutical development, drug discovery, disease diagnostics, vaccine production, agriculture, environmental research, and the food sector. The Biologics Development Services segment provides comprehensive support for drug development, assisting pharmaceutical, biotechnology, government, and academic organizations. This includes antibody drug discovery, preclinical and clinical development of antibody therapeutics, and the preclinical and clinical advancement of plasmids and viruses for gene and cell therapies. Within its Industrial Synthetic Biology Products segment, the company specializes in engineering non-pathogenic microbial strains and manufacturing industrial enzymes. These are applied across various industries, including food processing, animal feed, pharmaceuticals, and chemicals. Finally, the Cell Therapy division is dedicated to the discovery and development of chimeric antigen receptor T-cell (CAR T-cell) therapies specifically for treating both liquid and solid tumors. Established in 2002, Genscript Biotech Corporation is headquartered in Nanjing, People's Republic of China.
GNNSF Dividend & DRIP — Frequently Asked Questions
Does GNNSF pay a dividend?
No. Genscript Biotech Corporation (GNNSF) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of GNNSF?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does GNNSF have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. GNNSF has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to GNNSF
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full GNNSF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GNNSF position with:
🌍 GNNSF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold GNNSF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 GNNSF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 GNNSF Dividend Payment Schedule
GNNSF pays quarterly — 4 times per year. Ex-div: —.
📊 GNNSF vs Healthcare Benchmarks
How GNNSF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GNNSF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ GNNSF Insider Activity
No recent SEC filings reported in the last 90 days.Peer Group
Similar companies in the same sectorCompare GNNSF with peers: GNNSF vs BIO · GNNSF vs CRL · GNNSF vs TECH
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GNNSF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Genscript Biotech Corporation (GNNSF) is currently trading at $4.25, 35% below its 52-week high. It does not currently pay a regular dividend.
Does GNNSF Pay a Dividend? Genscript Biotech Corporation Dividend Status
Genscript Biotech Corporation (GNNSF) is a healthcare stock trading at $4.25. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest GNNSF News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your GNNSF DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.